Refractory Nodal Marginal Zone Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11703 | Acalabrutinib | 1 | Withdrawn | 1 |
DB05015 | Belinostat | 1 | Suspended | 1 |
DB08889 | Carfilzomib | 1 | Suspended | 1 |
DB12483 | Copanlisib | 1 | Suspended | 1 |
DB09331 | Daratumumab | 1 | Suspended | 1 |
DB11952 | Duvelisib | 1 | Withdrawn | 1 |
DB09502 | Fludeoxyglucose (18F) | 1 | Suspended | 1 |
DB13134 | Fluorine F-18 | 1 | Suspended | 1 |
DB00441 | Gemcitabine | 1 | Suspended | 1 |
DB00480 | Lenalidomide | 1 | Withdrawn | 1 |
DB09035 | Nivolumab | 1 | Suspended | 1 |
DB08935 | Obinutuzumab | 1 | Suspended | 1 |
DB09037 | Pembrolizumab | 1 | Suspended | 1 |
DB00073 | Rituximab | 1 | Suspended | 1 |
DB06176 | Romidepsin | 1 | Suspended | 1 |
DB00072 | Trastuzumab | 1 | Suspended | 1 |
DB00135 | Tyrosine | 1 | Withdrawn | 1 |
DB11850 | Ublituximab | 1 | Withdrawn | 1 |
DB14989 | Umbralisib | 1 | Withdrawn | 1 |
DB09053 | Ibrutinib | 2 | Completed | 1 |
DB09054 | Idelalisib | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Completed | 1 |
DB15102 | Pemigatinib | 2 | Not Yet Recruiting | 1 |